OneSource Specialty Pharma’s Bangalore facility maintains US FDA compliance with Voluntary Action Indicated status classification
OneSource Bangalore | 10/06/2025 | By Darshana | 255
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy